References 257further characterization of neuroantigens may provide appropriate therapeutic
interventions that may block the production of those specific neuroantigens,
and neutralize them by blocking antibodies (i.e., anti‐Rh antibodies given to
mothers with Rh‐incompatibility to protect against development of erythro
blastosis fetalis), thus raising the optimistic prospect that some future cases
of ASD or related neurodevelopmental and psychiatric disorders could be
prevented.
References
1 Zheng HC (2017). The molecular mechanisms of chemoresistance in cancers.
Oncotarget. DOI: 10.18632/oncotarget.19048.
2 Kirkland JL, Tchkonia T (2017). Cellular senescence: A translational
perspective. EBioMedicine, 21 :21–28.
3 Keyel PA (2017). DNAses in health and disease. Dev. Biol., pii: S0012‐1
606 (17)30222–1.
4 Agre P, Cartron JP (1991). Molecular biology of the Rh antigens. Blood,
78 (3):551–63.
5 Marsh WL (1990). Biological roles of blood group antigens. Yale J. Biol. Med.,
63 (5):455–60.
6 Clarke CA (1972). Some immunological interactions between mother and
foetus. Postgrad. Med. J., 48 (559):199–206.
7 Ternavasio‐de la Vega HG, Boronat M, Ojeda A, et al. (2010). Mumps orchitis
in the post‐vaccine era (1967‐2009): a single‐center series of 67 patients and
review of clinical outcome and trends. Medicine (Baltimore), 89 (2):96–116.
8 Clifford V, Wadsley J, Jenner B, Buttery JP (2010). Mumps vaccine associated
orchitis: Evidence supporting a potential immune‐mediated mechanism.
Vaccine, 28 (14):2671–3.
9 Hooper DC, Bagasra O, Marini JC, et al. (1997). Prevention of experimental
allergic encephalomyelitis by trageting nitric oxide and peroxynitrite:
Implications for the treatment of multiple sclerosis. Proc. Natl Acad. Sci.
(USA), 94 :2528–33.
10 Bagasra O, Michaels F, Zheng YM, et al. (1995). Activation of the inducible
form of nitric oxide synthetase in the brains of patients with multiple sclerosis.
Proc. Natl Acad. Sci. (USA), 92 :12041–45.
11 Bagasra O, Bobroski LE, Sarker A, et al. (1997). Absence of the inducible form
of nitric oxide synthase in the brains of patients with the acquired
immunodeficiency syndrome. J. Neurovirol., 3 :153–67.
12 Bagasra O, Pace DG (2013). Reassessing HIV Vaccine Design and Approaches:
Towards a Paradigm Shift. Nova Scientific Publications, Inc., New York.
13 Edmiston E, Ashwood P, Van de Water J (2017). Autoimmunity,
autoantibodies, and autism spectrum disorder. Biol. Psychiatry, 81 (5):383–90.